Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Regulated Information - Denominator
Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.
Leuven, BELGIUM, Boston, MA, US – November 16, 2023 – 07.00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Oxurion NV (Euronext Brussels: OXUR) (the “Company” or “Oxurion”), announces the below information, following the issuance of 135,869,565new ordinary shares on November 15, 2023, for a total amount of EUR 100,000, as the result of the conversion of 4 convertible bonds, pursuant to the Capital Commitment entered into with Atlas Special Opportunities, LLC.
Following completion of the capital increase through the conversion of the convertible bonds, the total number of shares issued by Oxurion amounts to 3,247,913,079 outstanding ordinary shares carrying voting rights (compared to 3,112,043,514 outstanding ordinary shares previously). This number will be used as the denominator for the calculation of the percentages of shareholdings.
Therefore, Oxurion publishes the following updated information:
Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel therapeutic for the treatment of DME. THR-149 is a potent plasma kallikrein inhibitor being developed as a potential new standard of care for the up to 50% of DME patients showing suboptimal response to anti-VEGF therapy. Oxurion is headquartered in Leuven, Belgium, with corporate operations in Boston, MA. More information is available at www.oxurion.com.
Important information about forward-looking statements
Certain statements in this press release may be considered “forward-looking”. Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company’s Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws.
For further information please contact:
Chief Executive Officer
Tel: +32 16 75 13 10
Chief Business Officer
Tel: +32 16 75 13 10
Mary T. Conway
AttachmentsTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Nokia Corporation Financial Calendar for 20241.12.2023 07:00:00 CET | Press release
Nokia Corporation Stock Exchange Release 1 December 2023 at 8:00 EET Nokia Corporation Financial Calendar for 2024 Espoo, Finland – In this stock exchange release, Nokia provides its financial calendar for 2024, which includes the planned publication dates of its financial reports. Planned publication dates for Nokia's financial reports in 2024: report for Q4 2023 and full year 2023: 25 January 2024report for Q1 2024: 18 April 2024report for Q2 2024 and half-year 2024: 18 July 2024report for Q3 2024 and January–September 2024: 17 October 2024 Publication of "Nokia in 2023" Nokia plans to publish its "Nokia in 2023" annual report, which includes the review by the Board of Directors and the audited annual accounts, during the week starting on 26 February 2024. Nokia's Annual General Meeting Nokia's Annual General Meeting 2024 is planned to be held on 3 April 2024. About Nokia At Nokia, we create technology that helps the world act together. As a B2B technology innovation leader, we are p
S&P Global Ratings raises its rating on CNH Industrial to ‘BBB+’1.12.2023 07:00:00 CET | Press release
Basildon, December 1, 2023 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces that on November 30, 2023, S&P Global Ratings raised its long-term issuer credit ratings on CNH Industrial N.V. and its subsidiary, CNH Industrial Capital LLC, to 'BBB+' from 'BBB'. S&P Global Ratings also affirmed the 'A-2' short-term issuer credit rating. Additionally, S&P Global Ratings raised the issue-level ratings on CNH Industrial N.V. and its industrial subsidiaries' debt, as well as the issue-level ratings on CNH Industrial Capital LLC's senior unsecured debt, to 'BBB+' from 'BBB'. The outlook is stable. CNH Industrial (NYSE: CNHI / MI: CNHI) is a world-class equipment and services company. Driven by its purpose of Breaking New Ground, which centers on Innovation, Sustainability and Productivity, the Company provides the strategic direction, R&D capabilities, and investments that enable the success of its global and regional Brands. Globally, Case IH and New Holland Agriculture supply 360° agricul
Canada Carbon Provides Update on Its Asbury Mine Exploration Program1.12.2023 04:04:42 CET | Press release
TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Canada Carbon Inc. (the "Company" or "Canada Carbon” or ("CCB"), (TSX-V:CCB), (FF:U7N1) is pleased to report that extensive graphitic mineralization was observed during its ongoing drill program on the Asbury Property (“the Property”). The Company would like to take this opportunity to provide a general update regarding the exploration program on the Property. Current exploration work includes drilling, completion of an NI 43-101 compliant resource calculation, metallurgical testing and development of a geochemical signature. The information provided from the exploration work will allow the Company to proceed with a Preliminary Economic Study to be completed in 2024. Drill Program Phase 1 of the drill program commenced on October 16th, and will be completed on November 30th 2023. The current drill program is testing a folded conductor anomaly, located on the North Eastern side of a regional magnetic anomaly. The drilled area is mostly located
Delårsrapport januari – september 202330.11.2023 23:59:00 CET | Pressemelding
Tredje kvartalet 2023 (jämfört med tredje kvartalet 2022) Nettoomsättningen uppgick till 8 MSEK (24)Bruttomarginalen ökade till 67 % (35 %)Rörelseresultatet ökade till 128 MSEK (-14)Periodens nettoresultat blev 122 MSEK (-4)Resultat per aktie före och efter utspädning ökade till 0,45 SEK (-0,05) Januari – september 2023 (jämfört med januari – september 2022) Nettoomsättningen uppgick till 30 MSEK (61)Bruttomarginalen ökade till 66 % (63 %)Rörelseresultatet ökade till 98 MSEK (-37)Nettoresultatet blev positivt och uppgick till 99 MSEK (-9)Resultat per aktie före och efter utspädning uppgick till 0,42 SEK (-0,17) Rapporten för januari – september 2023 i sin helhet finns tillgänglig på följande adress: https://www.anoto.com/investors/reports/ För ytterligare information kontakta: Joonhee Won, VD, Anoto Group AB För mer information om Anoto, besök www.anoto.com eller email email@example.com Denna information är sådan information som Anoto Group AB (publ) är skyldigt att offentliggöra enligt EU:
Interim Report January – September 202330.11.2023 23:59:00 CET | Press release
Third quarter 2023 (compared to third quarter 2022) Net sales for the quarter amounted to MSEK 8 (24)Gross margin for the quarter increased to 67% (35%)Operating profit increased to MSEK 128 (-14)Net income for the period turned to profit of MSEK 122 (-4)Earnings per share before and after dilution increased to SEK 0.45 (-0.05) January – September 2023 (compared to January – September 2022) Net sales for the period amounted to MSEK 30 (61)Gross margin for the period increased to 66% (63%)Operating profits increased to MSEK 98 (-37)Net income became positive at MSEK 99 (-9)Earnings per share before and after dilution increased to SEK 0.42 (-0.17) The report for January – September 2023 is available in its entirety on the following address: https://www.anoto.com/investors/reports/ For further information, please contact: Joonhee Won, CEO, Anoto Group AB For more information about Anoto, please visit www.anoto.com or email firstname.lastname@example.org This information is information that Anoto Group AB (